Invention Grant
- Patent Title: Compound having KDM5 inhibitory activity and pharmaceutical use thereof
-
Application No.: US17971844Application Date: 2022-10-24
-
Publication No.: US11691968B2Publication Date: 2023-07-04
- Inventor: Akito Kakuuchi , Shuhei Umemura , Masaki Asada , Anatoly Ruvinsky , Yan Zhang , Hidenori Takahashi , Goran Krilov , Daigo Inoyama , Kyle Konze , Mats Svensson
- Applicant: ONO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Osaka
- Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: WO TCN2020088925 2020.05.07
- Main IPC: C07D413/14
- IPC: C07D413/14
Abstract:
Disclosed are compounds of following formula (I):
in which all symbols have the same meanings as the definitions described in the specification; or a salt thereof. The compounds or a salt thereof are useful as a prophylactic and/or therapeutic agent for cancer, Huntington's disease, Alzheimer's disease and the like.
in which all symbols have the same meanings as the definitions described in the specification; or a salt thereof. The compounds or a salt thereof are useful as a prophylactic and/or therapeutic agent for cancer, Huntington's disease, Alzheimer's disease and the like.
Information query
